Journey Medical Corp
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 16 | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | – | – | – | – | – | 33.1% | 41.9% | 37.8% | 2.0% | 16.8% | 32.5% | 33.2% | 35.8% | 31.2% | 36.5% | 41.1% | 41.6% | 41.2% | 35.2% | 41.7% | 44.8% | 48.3% | 52.8% | 45.2% | 18.6% | 39.4% | 52.3% | 44.0% | 36.1% | 16.4% | 44.6% | 40.0% | 32.6% | 40.5% | 46.0% | 33.2% | 37.8% | |
| – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 66.9% | 58.1% | 62.2% | 98.0% | 83.2% | 67.5% | 66.8% | 64.2% | 68.8% | 63.5% | 58.9% | 58.4% | 58.8% | 64.8% | 58.3% | 55.2% | 51.7% | 47.2% | 54.8% | 81.4% | 60.6% | 47.7% | 56.0% | 63.9% | 83.6% | 55.4% | 60.0% | 67.4% | 59.5% | 54.0% | 66.8% | 62.2% | |
| – | 14,944.5% | 92.9% | 1,863.0% | 2,437.0% | 2,888.2% | 2,068.7% | 8,558.9% | 50.0% | 2,272.2% | 852.4% | 635.0% | 27.4% | 159.7% | – | – | – | – | 0.0% | 90.1% | 4.0% | 11.4% | 5.4% | 14.3% | 17.4% | 26.7% | 16.6% | 10.3% | 6.5% | 9.9% | 60.5% | 6.1% | 5.8% | 1.6% | 0.3% | 0.0% | 1.6% | 1.0% | 0.0% | 0.3% | 0.7% | |
| – | 6,954.6% | 42.3% | 1,062.5% | 1,274.6% | 1,853.1% | 2,028.0% | 10,204.0% | 104.3% | 6,905.2% | 2,309.0% | 1,985.3% | 95.0% | 401.9% | – | – | – | 42.4% | 58.1% | 51.0% | 54.8% | 86.0% | 63.2% | 83.1% | 96.6% | 87.6% | 108.8% | 70.7% | 25.0% | 79.6% | 64.6% | 69.5% | 77.9% | 73.9% | 80.4% | 79.2% | 68.4% | 61.3% | 63.3% | 58.8% | 62.9% | |
| – | 21,899.2% | 135.1% | 2,925.5% | 3,711.5% | 16,800.8% | 4,096.7% | 19,139.5% | 154.3% | 9,177.4% | 3,201.1% | 2,620.2% | 122.5% | 561.6% | 48.9% | 50.5% | 61.7% | 42.4% | 58.1% | 148.9% | 122.8% | 110.5% | 68.6% | 97.3% | 114.1% | 114.3% | 125.5% | 99.3% | 31.5% | 74.4% | 125.1% | 75.7% | 83.7% | 67.2% | 80.7% | 79.2% | 76.0% | 62.3% | 63.3% | 64.3% | 66.6% | |
| – | -21,799.2% | -35.1% | -2,825.5% | -3,611.5% | -16,700.8% | -3,996.7% | -19,039.5% | -54.3% | -9,110.5% | -3,143.0% | -2,558.0% | -24.5% | -478.4% | 18.7% | 16.3% | 2.5% | 26.4% | 5.5% | -90.0% | -64.5% | -51.7% | -3.8% | -39.0% | -58.9% | -62.6% | -78.3% | -44.6% | 49.9% | -13.8% | -77.4% | -19.7% | -19.8% | 16.4% | -25.3% | -19.2% | -8.7% | -2.8% | -9.3% | 2.5% | -4.4% | |
| – | – | 6.9% | – | 123.8% | 268.7% | 294.6% | 1,422.7% | 12.1% | 477.0% | 144.0% | 149.3% | 5.4% | 38.1% | – | 1.6% | 2.0% | 1.5% | 2.1% | 8.8% | 7.0% | 23.4% | 1.7% | 2.5% | 3.5% | 3.9% | 5.3% | 4.4% | 0.8% | 0.2% | 4.2% | 3.8% | 5.2% | 6.1% | 6.8% | 6.2% | 5.3% | 5.8% | 5.6% | 4.9% | 5.4% | |
| – | -21,437.0% | -32.9% | -2,768.2% | -3,617.8% | -16,808.1% | -4,170.7% | -19,817.4% | -61.2% | -9,280.9% | -3,201.5% | -2,644.0% | -27.0% | -499.6% | 17.2% | 14.7% | 0.6% | 24.9% | 3.4% | -100.0% | -71.5% | -76.6% | -5.5% | -41.5% | -62.5% | -66.6% | -83.0% | -48.7% | 48.9% | -13.2% | -80.1% | -22.6% | -16.3% | 11.6% | -31.0% | -24.9% | -13.1% | -7.8% | -14.0% | -1.6% | -8.9% | |
| – | 362.2% | 2.2% | 57.3% | 117.5% | 161.4% | 120.6% | -64.9% | 5.2% | 306.6% | -8.6% | 63.3% | 3.0% | 16.9% | 4.3% | 9.9% | 0.2% | 6.7% | 0.9% | -22.4% | -17.2% | 47.6% | 0.4% | -0.3% | 0.1% | 0.1% | -0.6% | -14.4% | 0.3% | 0.8% | 6.1% | – | – | 0.4% | – | 0.4% | – | – | – | 0.1% | – | |
| – | -21,437.0% | -32.9% | -2,768.2% | -3,617.8% | -16,808.1% | -4,170.7% | -19,817.4% | -61.2% | -9,280.9% | -3,201.5% | -2,644.0% | -27.0% | -499.6% | 12.9% | 4.8% | 0.3% | 18.2% | 2.5% | -77.6% | -54.3% | -124.2% | -5.9% | -41.2% | -62.5% | -66.7% | -83.0% | -48.7% | 48.6% | -14.0% | -80.1% | -22.6% | -16.3% | 11.2% | -31.0% | -25.3% | -13.1% | -7.8% | -14.0% | -1.7% | -9.0% | |
| – | 4,443.7% | -32.7% | -2,796.5% | -3,464.4% | -16,464.9% | -3,910.9% | -17,812.7% | -42.4% | -8,748.4% | -3,050.5% | -2,488.6% | -21.3% | -460.3% | 22.0% | 20.1% | 6.3% | 29.0% | 10.9% | -77.3% | 2.8% | -35.8% | 0.7% | -33.3% | -52.6% | -54.9% | -68.7% | -38.0% | 52.1% | -7.6% | -69.5% | -13.2% | -5.4% | 25.1% | -16.0% | -11.4% | -1.8% | 4.8% | -1.2% | 8.5% | 2.7% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.